JERUSALEM – Marking a pivotal moment in the growing relationship between China and Israel, the biggest pharma licensing agreement between the two countries recently took another step forward. Jerusalem-based Oramed Pharmaceuticals Inc. received the first milestone payment from its license and investment agreement with Hefei Tianhui Incubator of Technologies Co. Ltd. (HTIT), of Hefei, China.